Biblio

Export 3288 results:
Author Title Type [ Year(Desc)]
2018
S. P. Raikwar, Thangavel, R., Dubova, I., Ahmed, M. Ejaz, Selvakumar, P. Govindhasa, Kempuraj, D., Zaheer, S., Iyer, S., and Zaheer, A., “Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer's Disease: Are We There Yet?”, J Alzheimers Dis, vol. 65, no. 2, pp. 321-344, 2018.
A. J. Ehrenberg, Suemoto, C. K., Resende, Ede Paula F., Petersen, C., Leite, R. Elaine Par, Rodriguez, R. Diehl, Ferretti-Rebustini, R. Eloah de L., You, M., Oh, J., Nitrini, R., Pasqualucci, C. Augusto, Jacob-Filho, W., Kramer, J. H., Gatchel, J. R., and Grinberg, L. T., “Neuropathologic Correlates of Psychiatric Symptoms in Alzheimer's Disease.”, J Alzheimers Dis, vol. 66, no. 1, pp. 115-126, 2018.
J. Grizzanti, Corrigan, R., and Casadesus, G., “Neuroprotective Effects of Amylin Analogues on Alzheimer's Disease Pathogenesis and Cognition.”, J Alzheimers Dis, vol. 66, no. 1, pp. 11-23, 2018.
J. M. Zolezzi, Lindsay, C. B., Serrano, F. G., Ureta, R. C., Theoduloz, C., Schmeda-Hirschmann, G., and Inestrosa, N. C., “Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.”, J Alzheimers Dis, vol. 63, no. 2, pp. 705-723, 2018.
Y. Du, Fu, M., Wang, Y. Tian, and Dong, Z., “Neuroprotective Effects of Ginsenoside Rf on Amyloid-β-Induced Neurotoxicity in vitro and in vivo.”, J Alzheimers Dis, vol. 64, no. 1, pp. 309-322, 2018.
T. Ming Liew, Yu, J., Mahendran, R., Ng, T. - P., Kua, E. - H., and Feng, L., “Neuropsychiatric and Cognitive Subtypes among Community-Dwelling Older Persons and the Association with DSM-5 Mild Neurocognitive Disorder: Latent Class Analysis.”, J Alzheimers Dis, vol. 62, no. 2, pp. 675-686, 2018.
M. A. Sugarman, Alosco, M. L., Tripodis, Y., Steinberg, E. G., and Stern, R. A., “Neuropsychiatric Symptoms and the Diagnostic Stability of Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1841-1855, 2018.
W. S. Eikelboom, van Rooij, J. G. J., van den Berg, E., Coesmans, M., Jiskoot, L. C., Singleton, E., Ossenkoppele, R., van Swieten, J. C., Seelaar, H., and Papma, J. M., “Neuropsychiatric Symptoms Complicating the Diagnosis of Alzheimer's Disease: A Case Report.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1363-1369, 2018.
L. Alves, Cardoso, S., Maroco, J., de Mendonça, A., Guerreiro, M., and Silva, D., “Neuropsychological Predictors of Long-Term (10 Years) Mild Cognitive Impairment Stability.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1703-1711, 2018.
A. E. Medvedev, Radko, S. P., Yurinskaya, M. M., Vinokurov, M. G., Buneeva, O. A., Kopylov, A. T., Kozin, S. A., Mitkevich, V. A., and Makarov, A. A., “Neurotoxic Effects of Aβ6-42 Peptides Mimicking Putative Products Formed by the Angiotensin Converting Enzyme.”, J Alzheimers Dis, vol. 66, no. 1, pp. 263-270, 2018.
F. Hernández, Llorens-Martín, M., Bolós, M., Pérez, M., Cuadros, R., Pallas-Bazarra, N., Zabala, J. C., and Avila, J., “New Beginnings in Alzheimer's Disease: The Most Prevalent Tauopathy.”, J Alzheimers Dis, vol. 64, no. s1, pp. S529-S534, 2018.
P. Cisternas, Zolezzi, J. M., Lindsay, C., Rivera, D. S., Martinez, A., Bozinovic, F., and Inestrosa, N. C., “New Insights into the Spontaneous Human Alzheimer's Disease-Like Model Octodon degus: Unraveling Amyloid-β Peptide Aggregation and Age-Related Amyloid Pathology.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1145-1163, 2018.
A. Kaminari, Tsilibary, E. C., and Tzinia, A., “A New Perspective in Utilizing MMP-9 as a Therapeutic Target for Alzheimer's Disease and Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 64, no. 1, pp. 1-16, 2018.
L. Feng, Langsetmo, L., Yaffe, K., Sun, Y., Fink, H. A., Shikany, J. M., Leung, P. C., Lane, N. E., and Cauley, J. A., “No Effects of Black Tea on Cognitive Decline Among Older US Men: A Prospective Cohort Study.”, J Alzheimers Dis, vol. 65, no. 1, pp. 99-105, 2018.
F. Crunfli, Mazucanti, C. Henrique, de Moraes, R. Carlos Mac, Costa, A. Pereira, Rodrigues, A. Cristina, Scavone, C., and Torrão, Ada Silva, “NO-Dependent Akt Inactivation by S-Nitrosylation as a Possible Mechanism of STZ-Induced Neuronal Insulin Resistance.”, J Alzheimers Dis, vol. 65, no. 4, pp. 1427-1443, 2018.
S. Eun Kim, Woo, S., Kim, S. Woo, Chin, J., Kim, H. Jin, Lee, B. In, Park, J., Park, K. Won, Kang, D. - Y., Noh, Y., Ye, B. Seok, Yoo, H. Soo, San Lee, J., Kim, Y., Kim, S. Joo, Cho, S. Hyun, Na, D. L., Lockhart, S. N., Jang, H., and Seo, S. Won, “A Nomogram for Predicting Amyloid PET Positivity in Amnestic Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 66, no. 2, pp. 681-691, 2018.
O. Keret, Shochat, T., Steiner, I., and Glik, A., “Non-Ashkenazi Jewish Origin is Associated with Early Onset Alzheimer's Disease.”, J Alzheimers Dis, vol. 65, no. 3, pp. 877-884, 2018.
M. Cations, Draper, B., Low, L. - F., Radford, K., Trollor, J., Brodaty, H., Sachdev, P., Gonski, P., Broe, G. Anthony, and Withall, A., “Non-Genetic Risk Factors for Degenerative and Vascular Young Onset Dementia: Results from the INSPIRED and KGOW Studies.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1747-1758, 2018.
L. Calderón-Garcidueñas, Mukherjee, P. S., Waniek, K., Holzer, M., Chao, C. - K., Thompson, C., Ruiz-Ramos, R., Calderón-Garcidueñas, A., Franco-Lira, M., Reynoso-Robles, R., González-Maciel, A., and Lachmann, I., “Non-Phosphorylated Tau in Cerebrospinal Fluid is a Marker of Alzheimer's Disease Continuum in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 66, no. 4, pp. 1437-1451, 2018.
D. Brici, Götz, J., and Nisbet, R. M., “A Novel Antibody Targeting Tau Phosphorylated at Serine 235 Detects Neurofibrillary Tangles.”, J Alzheimers Dis, vol. 61, no. 3, pp. 899-905, 2018.
T. Panagaki, Gengler, S., and Holscher, C., “The Novel DA-CH3 Dual Incretin Restores Endoplasmic Reticulum Stress and Autophagy Impairments to Attenuate Alzheimer-Like Pathology and Cognitive Decrements in the APPSWE/PS1ΔE9 Mouse Model.”, J Alzheimers Dis, vol. 66, no. 1, pp. 195-218, 2018.
I. Piaceri, Imperiale, D., Ghidoni, E., Atzori, C., Bagnoli, S., Ferrari, C., Ungari, S., Ambrogio, L., Sorbi, S., and Nacmias, B., “Novel GRN Mutations in Alzheimer's Disease and Frontotemporal Lobar Degeneration.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1683-1689, 2018.
E. Lauretti and Praticò, D., “Novel Key Players in the Development of Tau Neuropathology: Focus on the 5-Lipoxygenase.”, J Alzheimers Dis, vol. 64, no. s1, pp. S481-S489, 2018.
A. Popelová, Pražienková, V., Neprašová, B., Kasperová, B. Judita, Hrubá, L., Holubová, M., Zemenová, J., Blum, D., Železná, B., Galas, M. - C., Kuneš, J., and Maletínská, L., “Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.”, J Alzheimers Dis, vol. 62, no. 4, pp. 1725-1736, 2018.
N. Baazaoui and Iqbal, K., “A Novel Therapeutic Approach to Treat Alzheimer's Disease by Neurotrophic Support During the Period of Synaptic Compensation.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1211-1218, 2018.

Pages